Jun 09, 2020 / 02:30PM GMT
Amit Hazan - Goldman Sachs Group, Inc., Research Division - Equity Analyst
All right. Good morning, everyone. We're back. I'm Amit Hazan, the medical technology analyst at Goldman Sachs. From my team, Jamie and Phil are probably on in the background as well. And we're excited to have as our next presenter, Hologic, a company we actually don't cover, but I used to back in the day. And so we've got Steve MacMillan, the Chairman, President and Chief Executive Officer, with us this morning; and Mike Watts might chime in as well, Vice President, Investor Relations. And so first and foremost, these are busy times for you guys, Steve. So I must say thank you so much for joining us, and welcome.
Stephen P. MacMillan - Hologic, Inc. - Chairman, CEO & President
Well, thank you, Amit. Good to see you again after all these years.
Amit Hazan - Goldman Sachs Group, Inc., Research Division - Equity Analyst
Yes. Likewise. My history with Hologic goes back a long way. It was a small-cap stock and Cytyc and Gen-Probe are all names I
Hologic Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 09, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers